Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Responses of metastatic basal cell and cutaneous squamous cell carcinomas to anti-PD1 monoclonal antibody REGN2810

Published:2016-11-15 Issue:1 Volume:4 Page:
ISSN:2051-1426
Container-title:Journal for ImmunoTherapy of Cancer
language:en
Short-container-title:j. immunotherapy cancer

Author:

Falchook Gerald S.,Leidner Rom,Stankevich Elizabeth,Piening Brian,Bifulco Carlo,Lowy Israel,Fury Matthew G.

Funder

Regeneron Pharmaceuticals

Publisher

BMJ

Subject

Cancer Research,Pharmacology,Oncology,Molecular Medicine,Immunology,Immunology and Allergy

Link

http://link.springer.com/content/pdf/10.1186/s40425-016-0176-3.pdf

Reference19 articles.

1. Chalmers ZR, Huang FW, Gay LM, Ali SM, Yelensky R. Broad analysis of recurrent somatic mutations in cancer reveals a common novel non-coding mutation in the promoter of PMS2 associated with greatly increased tumor mutation load. AACR Annual Meeting. 2016;abstract 3576.

2. Pickering CR, Zhou JH, Lee JJ, Drummond JA, Peng SA, Re S, Tsai KT, Curry JL, Tetzlaff MT, Lai SY, et al. Mutational landscape of aggressive cutaneous squamous cell carcinoma. Clin Canc Res. 2014;20:6582–92.

3. Bonilla X, Parmantier L, King B, Bezrukov F, Kaya G. Genomic analysis identifies new drivers and progression pathways in skin basal cell carcinoma. Nat Gen. 2016;48:398–406.

4. Le DT, Uram JN, Wang H, Bartlett BR, Kemberling H. PD-1 blockade in tumors with mismatch-repair deficiency. New Engl J Med. 2015;372(26):2509–20.

5. Mandal R, Chan TA. Personalized oncology meets immunology: the path towards precision immunotherapy. Cancer Discov. 2016;6:1–12.

Cited by 146 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of PD‐1 in Skin Cancer: Molecular Mechanism, Clinical Applications, and Resistance;Chemical Biology & Drug Design;2024-09

2. The Immunomodulatory Potential of Concurrent High-Dose Radiotherapy and Immune Checkpoint Inhibitor Cemiplimab in Advanced Cutaneous Squamous Cell Carcinoma: Initial Results;Journal of Personalized Medicine;2024-05-29

3. Regulatory mechanisms of PD-1/PD-L1 in cancers;Molecular Cancer;2024-05-18

4. The Use of Immune Regulation in Treating Head and Neck Squamous Cell Carcinoma (HNSCC);Cells;2024-02-27

5. Deciphering the Role of Immune-Checkpoint Inhibitors in Lung Cancer Treatment;Molecular Biomarkers for Cancer Diagnosis and Therapy;2024

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3